唐尧生物科技
济南华维医药科技有限公司
Huawei Pharmaceutical Co. Ltd.
  • 公司概况
  • 济南华维医药科技有限公司(原上海华潍医药正式迁入山东济南药谷)是中国一流的新药筛选专业CRO公司,本公司专注于提供1.1类新药在分子水平、细胞水平、动物水平上的药效学筛选服务。

          济南华维在分子水平上可以提供的筛选服务包括,聚合ADP核糖聚合酶,酪氨酸激酶,蛋白酪氨酸磷酸酶(PTP),丝/苏氨酸激酶,组蛋白去乙酰化酶,组蛋白去甲基化酶,组蛋白甲基转移酶,DNA甲基转移酶,热休克蛋白,基质金属蛋白酶,抑制微管蛋白聚集及解聚酶,蛋白酶体,拓扑异构酶,二肽基肽酶,去乙酰化酶,过氧化物酶体增殖剂激活受体,其他与代谢相关的酶,细胞毒T淋巴细胞相关抗原4,磷酸二酯酶,磷脂酶A,调节血脂,抗病毒,抗凝血,抗高血压,溴结构域蛋白,组织蛋白酶,凋亡相关,泛素相关,β淀粉样蛋白,乙酰胆碱酯酶等,共计500余种新药靶点,涉及的疾病种类为抗肿瘤,抗糖尿病,抗炎症,免疫调节,抗病毒,心脑血管病,血液系统疾病,阿尔茨海默病等。

          济南华维在细胞水平上可以针对十几条主要的信号通路进行抑制剂的筛选,包括 cAMP/CRE/CREB通路, Hedgehog通路, JAK/STAT通路,JNK通路,. MEK/ERK通路,NF-KB通路, Notch通路, Nrf2 antioxidant通路, PI3K/AKT通路, Wnt/ catenin通路,RAR Nuclear receptor通路,TGF/SMAD通路。我公司建有较齐全的细胞库,可以针对各种正常细胞及肿瘤细胞开展细胞增殖抑制实验,细胞周期阻滞实验,细胞凋亡实验,细胞迁移实验,细胞转染及RNA干扰实验,细胞集落形成实验,针对耐药细胞株的增殖抑制实验,细胞水平的P糖蛋白底物抑制剂检测,DNA Ladder实验,基因过表达及基因沉默实验,细胞骨架免疫荧光实验,蛋白免疫印迹Western blot 实验,大鼠动脉环实验,HUVEC的管腔形成实验,活细胞水平HDAC抑制的测试,PARP的增敏细胞实验。

    济南华维拥有符合国际标准的动物饲养管理设施和现代化的功能实验室。动物饲养设施可饲养裸鼠、小鼠、大鼠、豚鼠、兔等实验动物;技术人员熟练掌握静脉注射、肌肉注射、皮下注射、腹腔注射、口服给药、经皮给药、吸入及鼻腔喷雾、滴眼及视网膜下注射等给药方式及动静脉等多种取血方式。可以对抗肿瘤药物,抗糖尿病药物及抗炎症药物,通过相应的实验动物模型进行药效学评价。

           济南华维的核心团队均具有博士学位,在大型制药企业或CRO公司从事过多年的药物筛选与开发经验,曾成功完成近百个IND的研究与申报,涵盖药物研发的多数热点领域。公司还拥有强大的顾问团队,他们均来自于药物研发的一线,能够精确把握最新的药物筛选与开发的热点技术和趋势,他们分别就职于国内外著名的科研院所、监管评审机构以及世界前十大药厂。本公司可以为客户提供最热门药物靶点相关的新药快速筛选的相关CRO服务,可以极大的提高客户进行新药筛选的实验效率,节约实验成本。        

           济南华维将以最先进的理念和最高的质量服务于客户,以缩短客户研发周期和减少客户研发成本为服务宗旨,在生物技术领域提供一如既往高品质的产品与服务,期待与您的合作!








  • 更多信息>>
  • 联系我们
  • 电 话:   15821697315 微信号: 15821697315 QQ: 1621015150
  • 0531-58990387
  • 传 真:   021-64828900
  • E-mail
  • 1621015150@qq.com
  • QQ
  • 欢迎在线咨询
  • FDA审批第一个仿制爱妥糖锭(Actos)用于II型糖尿病的治疗
  • The U.S. Food and Drug Administration today approved the first generic version of Actos (pioglitazone hydrochloride) tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in adults with type 2 diabetes.

    Mylan Pharmaceuticals, based in Morgantown, W.Va., gained FDA approval for 15 milligram, 30 mg and 45 mg pioglitazone tablets.

    “Controlling blood sugar levels is very important in preventing or reducing the long-term health complications of diabetes,” said Gregory P. Geba, M.D., M.P.H., director of the Office of Generic Drugs in FDA’s Center for Drug Evaluation and Research. “Generic versions of this widely used product will offer affordable treatment options for patients who must manage this chronic and potentially serious condition.”

    Diabetes is a disease in which blood glucose, or sugar, levels are too high. Glucose comes largely from the food we eat. Insulin is a hormone that helps move glucose into the body’s cells to help them produce energy. In people with type 2 diabetes the body does not make or use insulin well. Without enough insulin, glucose stays in the blood. Over time, too much glucose in the blood can cause serious health problems such as damage to eyes, kidneys, and nerves. Diabetes can also contribute to heart disease, and stroke.

    Pioglitazone is dispensed with a patient Medication Guide that provides important instructions about its use and drug safety information. The drug has a Boxed Warning to emphasize that pioglitazone may cause or worsen heart failure, particularly in certain patient populations. Careful monitoring of patients when starting the drug or increasing the dose is recommended. The product label also notes that the use of pioglitazone for more than one year may be associated with an increased risk of bladder cancer.

    The most common side effects reported by patients using pioglitazone include cold-like symptoms, headache, sinus infection, muscle pain, and sore throat. Information about the availability of generic pioglitazone can be obtained from the manufacturer.

    Generic drugs approved by FDA are of the same high quality and strength as brand-name drugs. The generic manufacturing and packaging sites must pass the same quality standards as those for brand-name drugs.

    For more information:

    Pioglitazone HCI Information1

    NIH: National Diabetes Education Program2 

    FDA: Understanding Generic Drugs3

    Information on specific drug products, including prescribing information (labeling) and approval histories: Drugs@FDA4
     

    The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

  • 关闭  打印 登出时间 2012-09-07
  • 地址:山东省济南市高新区港兴三路济南药谷1号楼A座2508
  • 电话:15821697315 微信号: 15821697315 QQ: 1621015150 / 0531-58990387   传真:021-64828900
  • Powered by TANG 3.6 Copyright @ 2012 - 2015 唐尧生物